Standardised animal models of host microbial mutualism

Mucosal Immunology

Volumn 8, Issue 3, 2015, Pages 476-486

  Macpherson, A J ^a   McCoy, K D ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; AXENIC CULTURE; BACTERIAL GENOME; BACTERIAL TRANSMISSION; BIOSPHERE; EXPERIMENTAL ANIMAL; GNOTOBIOTICS; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; MICROBIAL COLONIZATION; MICROBIAL DIVERSITY; MICROBIAL METABOLISM; MICROFLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMBIOSIS; ANIMAL; ANIMAL MODEL; EMBRYO TRANSFER; FOUNDER EFFECT; GENETIC HETEROGENEITY; GERMFREE ANIMAL; GERMLINE MUTATION; IMMUNOLOGY; TRANSGENIC MOUSE;

ANIMALS; EMBRYO TRANSFER; FOUNDER EFFECT; GENETIC HETEROGENEITY; GERM-FREE LIFE; GERM-LINE MUTATION; HOST-PATHOGEN INTERACTIONS; HUMANS; MICE, TRANSGENIC; MICROBIOTA; MODELS, ANIMAL; SYMBIOSIS;

EID: 84928881439     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.113     Document Type: Review

References (88)

1. Pasteur, L. Observations relatives a la note de M. Duclaux. Compt. Rend. 100, 69 (1885).
2. Cushing, H. & Livingood, L.E. Experimental and surgical notes upon the bacteriology of the upper portion of he alimentary canal, with observations on the establishment there of an amicrobic state as a preliminary to operative procedures on the stomach and small intestine. John's Hopkins Hospital Rep. 9, 543-549 (1900).
3. Cohendy, M. Experiences sur la vie sans microbes. Compt. Rend. 154, 533-536 (1912).
4. Cohendy, M. Experiences sur la vie sans microbes, élevage aseptique de cobages. Compt. rend 158, 1283-1284 (1914).
5. Glimstedt, G. Bakterienfrei Meerschweinchen. Aufzucht, Lebensfähigkeit und Wachstum, nebst Untersuchung über das lymphatische Gewebe. Acta Pathol. Microbiol. Scand. Suppl. 30, 1-295 (1936).
6. Smith, K., McCoy, K.D. & Macpherson, A.J. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol. 19, 59-69 (2007).
7. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27-30 (2000).
8. Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174-180 (2011).
9. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
10. Blottiere, H.M., de Vos, W.M., Ehrlich, S.D. & Dore, J. Human intestinal metagenomics: state of the art and future. Curr. Opin. Microbiol. 16, 232-239 (2013).
11. Cotillard, A. et al. Dietary intervention impact on gut microbial gene richness. Nature 500, 585-588 (2013).
12. Wilson, K.H., Brown, R.S., Andersen, G.L., Tsang, J. & Sartor, B. Comparison of fecal biota from specific pathogen free and feral mice. Anaerobe 12, 249-253 (2006).
13. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
14. Ubeda, C. et al. Familial transmission rather than defective innate immunity shapes the distinct intestinal microbiota of TLR-deficient mice. J. Exp. Med. 209, 1445-1456 (2012).
15. McCafferty, J. et al. Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model. ISME J. 7, 2116-2125 (2013).
16. Morse, H.C. Origins of Inbred Mice. Academic Press, (available online athttp://www.informatics.jax.org/morsebook/index.shtml1978).
17. Guillen, J. FELASA guidelines and recommendations. J. Am. Assoc. Lab. Anim. Sci. 51, 311-321 (2012).
18. Mahler, M. et al. FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units. Lab. Anim. 48, 178-192 (2014).
19. Talham, G.L., Jiang, H.Q., Bos, N.A. & Cebra, J.J. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect. Immun. 67, 1992-2000 (1999).
20. Klaasen, H.L. et al. Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune systemofmice. Infect. Immun. 61, 303-306 (1993).
21. Ivanov, I.I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009).
22. Yang, Y. et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 510, 152-156 (2014).
23. Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689 (2009).
24. Salzman, N.H. et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11, 76-83 (2010).
25. Wu, H.J. et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827 (2010).
26. Lee, Y.K., Menezes, J.S., Umesaki, Y. & Mazmanian, S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 108 (Suppl 1), 4615-4622 (2011).
27. Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564-568 (2014).
28. Sczesnak, A. et al. The genome of th17 cell-inducing segmented filamentous bacteria reveals extensive auxotrophy and adaptations to the intestinal environment. Cell Host Microbe 10, 260-272 (2011).
29. Pamp, S.J., Harrington, E.D., Quake, S.R., Relman, D.A. & Blainey, P.C. Single-cell sequencing provides clues about the host interactions of segmented filamentous bacteria (SFB). Genome Res. 22, 1107-1119 (2012).
30. Mazmanian, S.K. & Kasper, D.L. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 6, 849-858 (2006).
31. Mazmanian, S.K., Liu, C.H., Tzianabos, A.O. & Kasper, D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118 (2005).
32. Round, J.L. et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974-977 (2011).
33. Dasgupta, S., Erturk-Hasdemir, D., Ochoa-Reparaz, J., Reinecker, H.C. & Kasper, D.L. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe 15, 413-423 (2014).
34. Roediger, W.E. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21, 793-798 (1980).
35. Smith, P.M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573 (2013).
36. Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455 (2013).
37. Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450 (2013).
38. Atarashi, K. et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232-236 (2013).
39. Holmes, E., Li, J.V., Athanasiou, T., Ashrafian, H. & Nicholson, J.K. Understanding the role of gutmicrobiome-host metabolic signal disruption in health and disease. Trends Microbiol. 19, 349-359 (2011).
40. Swann, J.R. et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl Acad. Sci. USA 108 (Suppl 1), 4523-4530 (2011).
41. Kullberg, M.C. et al. IL-23 plays a key role in Helicobacter hepaticusinduced T cell-dependent colitis. J. Exp. Med. 203, 2485-2494 (2006).
42. Kullberg, M.C. et al. Bacteria-triggered CD4+ T Regulatory Cells Suppress Helicobacter hepaticus-induced Colitis. J. Exp. Med. 196, 505-515 (2002).
43. Maloy, K.J., Salaun, L., Cahill, R., Dougan, G., Saunders, N.J. & Powrie, F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111-119 (2003).
44. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375 (2010).
45. Powell, N. et al. The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 37, 674-684 (2012).
46. Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185 (2012).
47. Backhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718-15723 (2004).
48. Markle, J.G. et al. Sex differences in the gut microbiome drive hormonedependent regulation of autoimmunity. Science 339, 1084-1088 (2013).
49. Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63 (2011).
50. Cryan, J.F. & Dinan, T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13, 701-712 (2012).
51. Sears, C.L. & Garrett, W.S. Microbes, microbiota, and colon cancer. Cell Host Microbe 15, 317-328 (2014).
52. Goodman, A.L. et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc. Natl Acad. Sci. USA 108, 6252-6257 (2011).
53. Turnbaugh, P.J., Backhed, F., Fulton, L. & Gordon, J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223 (2008).
54. Goldsmith, J.R. & Sartor, R.B. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J. Gastroenterol. 49, 785-798 (2014).
55. Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222-227 (2012).
56. Costello, E.K., Stagaman, K., Dethlefsen, L., Bohannan, B.J. & Relman, D.A. The application of ecological theory toward an understanding of the human microbiome. Science 336, 1255-1262 (2012).
57. Lozupone, C.A. & Knight, R. Species divergence and the measurement of microbial diversity. FEMS Microbiol. Rev. 32, 557-578 (2008).
58. Nagy, A., Gertenstein, M., Vintersten, K. & Behringer, R. Spenectomy. Manipulating the Mouse Embryo. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, pp) 280-281 (2003).
59. Russell, E.S. One man's influence: a tribute to William Ernest Castle. J. Hered. 45, 210-213 (1954).
60. Gluecksohn-Schoenheimer, S. The development of two tailless mutants in the house mouse. Genetics 23, 573-584 (1938).
61. Gluecksohn-Schoenheimer, S. The effect of an early lethal (to) in the house mouse. Genetics 25, 391-400 (1940).
62. Billingham, R.E., Brent, L. & Medawar, P.B. Quantitative Studies on Tissue Transplantation Immunity. III. Actively Acquired Tolerance. Phil. Trans. R. Soc. Lond. B 239, 357-414 (1956).
63. Zinkernagel, R.M. & Doherty, P.C. Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis. Nature 251, 547-548 (1974).
64. Zinkernagel, R.M. & Doherty, P.C. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. Nature 248, 701-702 (1974).
65. Webster, L.T. Microbic Virulence and Host Susceptibility in Paratyphoid-Enteritidis Infection of White Mice: Iv. The Effect of Selective Breeding on Host Resistance. J. Exp. Med. 39, 879-886 (1924).
66. Gorer, P.A., Lyman, S. & Snell, G.D. Studies on the genetic and antigenic basis of tumour transplantation. Linkage between a histocompatibility gene and 'fused' in mice. Proc. Roy. Soc. Lond. B 135, 499-505 (1948).
67. Evans, M.J. & Kaufman, M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981).
68. Martin, G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634-7638 (1981).
69. Miyakawa, M. The lymphatic system of germ free guinea pigs. Ann. N Y Acad. Sci. 78, 221-236 (1959).
70. Dubos, R. & Schaedler, R.W. The effect of the intestinal flora on the growth rate of mice, and on their susceptibility to experimental infections. J. Exp. Med. 111, 407-411 (1960).
71. Schaedler, R.W., Dubos, R. & Costello, R. Association of germfree mice with bacteria isolated from normal mice. J. Exp. Med. 122, 77-83 (1965).
72. Trexler, P.C. & Orcutt, R.P. Development of Gnotobiotics and Contamination Control in Laboratory Animal Science. 50 years of laboratory animal science. American Association for Laboratory Animal Science: New York, pp 121-128 (1999).
73. Orcutt, R.P., Gianni, F.J. & Judge, R.J. Development of an 'Altered Schaedler flora' for NCI gnotobiotic rodents. Microecol. Ther. 17, 59 (1987).
74. Dewhirst, F.E. et al. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl. Environ. Microbiol. 65, 3287-3292 (1999).
75. Stehr, M. et al. Charles River altered Schaedler flora (CRASF) remained stable for four years in a mouse colony housed in individually ventilated cages. Lab. Anim 43, 362-370 (2009).
76. Norin, E. & Midtvedt, T. Intestinal microflora functions in laboratory mice claimed to harbor a 'normal' intestinal microflora. Is the SPF concept running out of date?. Anaerobe 16, 311-313 (2010).
77. Reyes, A. et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466, 334-338 (2010).
78. Mills, S., Shanahan, F., Stanton, C., Hill, C., Coffey, A. & Ross, R.P. Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut microbes 4, 4-16 (2013).
79. De Paepe, M., Leclerc, M., Tinsley, C.R. & Petit, M.A. Bacteriophages: an underestimated role in human and animal health?. Front. Cell. Infect Microbe 4, 39 (2014).
80. Reyes, A., Wu, M., McNulty, N.P., Rohwer, F.L. & Gordon, J.I. Gnotobiotic mouse model of phage-bacterial host dynamics in the human gut. Proc. Natl Acad. Sci. USA 110, 20236-20241 (2013).
81. Modi, S.R., Lee, H.H., Spina, C.S. & Collins, J.J. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 499, 219-222 (2013).
82. Huffnagel, G.B. & Noverr, M.C. The emerging world of the fungal microbiome. Trends Microbiol. 21, 334-341 (2013).
83. Russell, W.M.S. & Birch, R.L. The Principles of Humane Experimental Technique. Methuen, London, 1959).
84. Wells, D.J. Animal welfare and the 3Rs in European biomedical research. Ann. N Y Acad. Sci. 1245, 14-16 (2011).
85. Chia, R., Achilli, F., Festing, M.F. & Fisher, E.M. The origins and uses of mouse outbred stocks. Nat. Genet. 37, 1181-1186 (2005).
86. Flint, J., Valdar, W., Shifman, S. & Mott, R. Strategies for mapping and cloning quantitative trait genes in rodents. Nat. Rev. 6, 271-286 (2005).
87. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
88. Sunagawa, S. et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat. methods 10, 1196-1199 (2013).